Samrat Pharmachem Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 116063,
    "name": "Samrat Pharma",
    "stock_name": "Samrat Pharma",
    "full_name": "Samrat Pharmachem Ltd",
    "name_url": "stocks-analysis/samrat-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "232.00",
    "chg": 8.95,
    "chgp": "4.01%",
    "dir": 1,
    "prev_price": "223.05",
    "mcapval": "69.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530125,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE103E01016",
    "curr_date": "Sep 25, 03:30 PM",
    "curr_time": "04:56 AM",
    "last_traded_at": "Sep 25, 03:30 PM IST",
    "bse_nse_vol": "2.26 k",
    "exc_status": "Active",
    "traded_date": "Sep 25, 2026",
    "traded_date_str": "2026 09 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/samrat-pharma-116063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-4204852",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SamratPharmache_mojoScore_4204852.png",
        "date": "2026-09-25 10:10:21",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 07 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 September 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Technical Setbacks",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-technical-setbacks-4185863",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SamratPharmache_mojoScore_4185863.png",
        "date": "2026-09-08 08:13:49",
        "description": "Samrat Pharmachem Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 7 September 2026. This shift reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid persistent underperformance and negative earnings."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-sell-by-marketsmojo-4182345",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SamratPharmache_mojoScore_4182345.png",
        "date": "2026-09-04 10:11:07",
        "description": "Samrat Pharmachem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Aug 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-sell-4165887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SamratPharmache_mojoScore_4165887.png",
        "date": "2026-08-23 10:10:27",
        "description": "Samrat Pharmachem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 August 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 23 August 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-4150017",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SamratPharmache_mojoScore_4150017.png",
        "date": "2026-08-12 10:11:22",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 August 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 12 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Golden Cross Forms in Samrat Pharmachem Ltd — On a Day the Stock Fell 0.27%. What the Mixed Signals Mean",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4140328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SamratPharmache_goldencross_4140328.png",
        "date": "2026-08-06 18:00:13",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Samrat Pharmachem Ltd, signalling a golden cross on 6 Aug 2026. Yet, the stock declined 0.27% on the day the cross formed, while monthly technical indicators remain mixed. This divergence between the moving averages and other signals calls for a detailed examination of the signal's reliability."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-4131226",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SamratPharmache_mojoScore_4131226.png",
        "date": "2026-08-01 10:10:22",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-4112462",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SamratPharmache_mojoScore_4112462.png",
        "date": "2026-07-21 10:10:29",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-4096345",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SamratPharmache_mojoScore_4096345.png",
        "date": "2026-07-10 10:10:30",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      }
    ],
    "total": 5764,
    "sid": "116063",
    "stock_news_url": "https://www.marketsmojo.com/news/samrat-pharmachem-116063"
  },
  "announcements": [
    {
      "caption": "Scrutinizers Report",
      "datetime": "24-Sep-2026",
      "details": "Scrutinizers Report & Voting Results for 34th AGM",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s",
      "datetime": "24-Sep-2026",
      "details": "The share holders of the company at the 34th AGM held on 23-09-2026 have approved the appointment of M/s. Divyesh J Shah & Associates Chartered Accountants as Statutory Auditors of the Company in place of the retiring auditors M/s. Shah & Savla LLP to hold office for a term of five years from conclusion of 34th AGM till the conclusion of 39th AGM to be held in 2031. Appointed with effect from 23-09-2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "23-Sep-2026",
      "details": "The Companys 34th AGM was held on 23rd September 2026 and the business mentioned in the prior notice was transacted.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Samrat Pharmachem Ltd has declared <strong>10%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Samrat Pharmachem Ltd is Rated Strong Sell

2026-09-25 10:10:21

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 07 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 September 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Samrat Pharmachem Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Technical Setbacks

2026-09-08 08:13:49

Samrat Pharmachem Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 7 September 2026. This shift reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid persistent underperformance and negative earnings.

Read full news article

Samrat Pharmachem Ltd is Rated Sell by MarketsMOJO

2026-09-04 10:11:07

Samrat Pharmachem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Aug 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Samrat Pharmachem Ltd is Rated Sell

2026-08-23 10:10:27

Samrat Pharmachem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 August 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 23 August 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-08-12 10:11:22

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 August 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 12 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Golden Cross Forms in Samrat Pharmachem Ltd — On a Day the Stock Fell 0.27%. What the Mixed Signals Mean

2026-08-06 18:00:13

The 50-day moving average has crossed above the 200-day moving average for Samrat Pharmachem Ltd, signalling a golden cross on 6 Aug 2026. Yet, the stock declined 0.27% on the day the cross formed, while monthly technical indicators remain mixed. This divergence between the moving averages and other signals calls for a detailed examination of the signal's reliability.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-08-01 10:10:22

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-07-21 10:10:29

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-07-10 10:10:30

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

View All News